Incretin-Pathway Peptides
Cagrilintide
An acylated amylin analogue supplied as a sealed lyophilized vial for receptor-pharmacology and stability research.
5mg · 10mg · 20mg
View Details
Incretin-Pathway Peptides
Retatrutide and tirzepatide combined at a defined nominal mass ratio, sealed as a lyophilized vial for comparative research.
Research use only
RTT60 combines retatrutide and tirzepatide at a defined nominal mass ratio in a single lyophilized vial. It sits in the incretin-pathway section as a two-component counterpart to the single-molecule retatrutide and tirzepatide entries.
This blend is intended for controlled in-vitro comparison between the two components, analytical characterization of the combined preparation, and component-compatibility research. Because it is a two-peptide blend, the exact mass ratio and any single molecular identifier are set out per batch in the documentation rather than on this page.
The vial is sealed after freeze-drying and labeled with a total nominal mass of 60mg. Batch documentation is confirmed by inquiry.
| Purity | ≥99% by HPLC |
|---|---|
| CAS number | See batch documentation |
| Molecular weight | See batch documentation |
| Molecular formula | See batch documentation |
| Material class | Two-component peptide blend |
| Appearance | White to off-white lyophilized powder |
| Available vial sizes | 60mg total |
| Documentation | Batch documentation confirmed on request |